KA
SGNT

Kerrisdale Advisers’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History

Kerrisdale Advisers’s Portfolio SGNT Stock Details SGNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-190,372
Closed -$2.85M – 42
2016
Q2 		$2.85M Sell
190,372
-13,754
-7% -$177K 0.77% 26
2016
Q1 		$2.48M Buy
+204,126
New +$2.86M 0.42% 35

Kerrisdale Advisers's SGNT Position: Q3 2016 in Review

Kerrisdale Advisers sold out of SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) in Q3 2016, closing a stake of 190,372 shares — an estimated $2.85M sold.

Kerrisdale Advisers first reported a position in SGNT in Q1 2016 and held it in 2 quarters. The position peaked at $2.85M in Q2 2016. 0 funds tracked by Wall St. Rank hold SGNT as of Q3 2016.

  • Kerrisdale Advisers reported no remaining SAGENT PHARMACEUTICALS INC COM STK (DE) position as of Q3 2016 after selling out during the quarter.
  • Kerrisdale Advisers sold 190,372 SAGENT PHARMACEUTICALS INC COM STK (DE) shares in Q3 2016, an estimated $2.85M.
  • Kerrisdale Advisers first reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) in Q1 2016 and held it in 2 quarters.
  • Kerrisdale Advisers's SAGENT PHARMACEUTICALS INC COM STK (DE) position peaked at $2.85M in Q2 2016.
  • 0 funds tracked by Wall St. Rank held SAGENT PHARMACEUTICALS INC COM STK (DE) as of Q3 2016.

Based on Kerrisdale Advisers's 13F filing for Q3 2016, filed 10 Nov 2016.